ES8101532A1 - Un procedimiento para la preparacion de acetofenonas substi-tuidas - Google Patents
Un procedimiento para la preparacion de acetofenonas substi-tuidasInfo
- Publication number
- ES8101532A1 ES8101532A1 ES488013A ES488013A ES8101532A1 ES 8101532 A1 ES8101532 A1 ES 8101532A1 ES 488013 A ES488013 A ES 488013A ES 488013 A ES488013 A ES 488013A ES 8101532 A1 ES8101532 A1 ES 8101532A1
- Authority
- ES
- Spain
- Prior art keywords
- preparation
- substituted
- lower alkoxy
- formula
- processes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000002360 preparation method Methods 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 2
- 150000008062 acetophenones Chemical class 0.000 title 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 3
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- -1 heterocyclic carboxylic acid Chemical class 0.000 abstract 2
- 239000002253 acid Substances 0.000 abstract 1
- 125000004423 acyloxy group Chemical group 0.000 abstract 1
- 125000001931 aliphatic group Chemical group 0.000 abstract 1
- 125000005194 alkoxycarbonyloxy group Chemical group 0.000 abstract 1
- 125000004414 alkyl thio group Chemical group 0.000 abstract 1
- 125000005530 alkylenedioxy group Chemical group 0.000 abstract 1
- 125000005336 allyloxy group Chemical group 0.000 abstract 1
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 125000004663 dialkyl amino group Chemical group 0.000 abstract 1
- 125000002541 furyl group Chemical group 0.000 abstract 1
- 125000001475 halogen functional group Chemical group 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 125000004076 pyridyl group Chemical group 0.000 abstract 1
- 125000000168 pyrrolyl group Chemical group 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- 125000001544 thienyl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/333—Radicals substituted by oxygen or sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
- C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
- C07C45/72—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction of compounds containing >C = O groups with the same or other compounds containing >C = O groups
- C07C45/74—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction of compounds containing >C = O groups with the same or other compounds containing >C = O groups combined with dehydration
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
- C07C49/84—Ketones containing a keto group bound to a six-membered aromatic ring containing ether groups, groups, groups, or groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
- C07D213/46—Oxygen atoms
- C07D213/50—Ketonic radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/80—Acids; Esters in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/40—Radicals substituted by oxygen atoms
- C07D307/46—Doubly bound oxygen atoms, or two oxygen atoms singly bound to the same carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
- C07D317/54—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/22—Radicals substituted by doubly bound hetero atoms, or by two hetero atoms other than halogen singly bound to the same carbon atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Oncology (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrrole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Pyridine Compounds (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB7902907 | 1979-01-26 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES488013A0 ES488013A0 (es) | 1980-12-16 |
| ES8101532A1 true ES8101532A1 (es) | 1980-12-16 |
Family
ID=10502766
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES488013A Expired ES8101532A1 (es) | 1979-01-26 | 1980-01-25 | Un procedimiento para la preparacion de acetofenonas substi-tuidas |
| ES495076A Granted ES495076A0 (es) | 1979-01-26 | 1980-09-16 | Un procedimiento para la preparacion de acetofenonas substi-tuidas |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES495076A Granted ES495076A0 (es) | 1979-01-26 | 1980-09-16 | Un procedimiento para la preparacion de acetofenonas substi-tuidas |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US4605674A (cg-RX-API-DMAC7.html) |
| EP (1) | EP0013960B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JPS567736A (cg-RX-API-DMAC7.html) |
| AR (1) | AR228131A1 (cg-RX-API-DMAC7.html) |
| AT (1) | ATE1744T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU537855B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR8000507A (cg-RX-API-DMAC7.html) |
| CA (1) | CA1124254A (cg-RX-API-DMAC7.html) |
| CS (1) | CS214819B2 (cg-RX-API-DMAC7.html) |
| DE (1) | DE3061010D1 (cg-RX-API-DMAC7.html) |
| DK (1) | DK32780A (cg-RX-API-DMAC7.html) |
| ES (2) | ES8101532A1 (cg-RX-API-DMAC7.html) |
| FI (1) | FI70699C (cg-RX-API-DMAC7.html) |
| GR (1) | GR73099B (cg-RX-API-DMAC7.html) |
| HU (1) | HU183108B (cg-RX-API-DMAC7.html) |
| IE (1) | IE49502B1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL59180A (cg-RX-API-DMAC7.html) |
| MC (1) | MC1303A1 (cg-RX-API-DMAC7.html) |
| NO (1) | NO151702C (cg-RX-API-DMAC7.html) |
| NZ (1) | NZ192641A (cg-RX-API-DMAC7.html) |
| PH (1) | PH16033A (cg-RX-API-DMAC7.html) |
| PT (1) | PT70729A (cg-RX-API-DMAC7.html) |
| YU (1) | YU19980A (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA80312B (cg-RX-API-DMAC7.html) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUT35173A (en) * | 1978-03-15 | 1985-06-28 | Wellcome Found | Process for production of medical preparatives consosting of - as reagent - flavane derivatives with antivirus influence |
| CA1137082A (en) * | 1979-05-23 | 1982-12-07 | Isao Umeda | Substituted acetophenones and process therefor |
| CA1206964A (en) * | 1980-11-12 | 1986-07-02 | Nobuo Shinma | Tetra-substituted benzene derivatives |
| KR890700117A (ko) * | 1986-12-12 | 1989-03-02 | 쓰무라 아끼라 | 유효성분으로서 칼콘 유도체를 함유하는 항 궤양제 및 신규의 칼콘 유도체 |
| US5234951A (en) * | 1986-12-12 | 1993-08-10 | Tsumura Juntendo, Inc. | Anti-ulcer agent comprising chalcone derivative |
| LU86715A1 (fr) * | 1986-12-16 | 1988-07-14 | Oreal | Composition cosmetique contenant des derives hydroxyles de chalcone et son utilisation pour la protection de la peau et des cheveux contre les radiations lumineuses,nouveaux derives hydroxyles de chalcone utilises et leur procede de preparation |
| US4863968A (en) * | 1987-04-09 | 1989-09-05 | Merrell Dow Pharmaceuticals Inc. | Methods of treating gout with chalcone derivatives |
| AU608821B2 (en) * | 1987-04-09 | 1991-04-18 | Merrell Dow Pharmaceuticals Inc. | Methods of treating gout with chalcone derivatives |
| US4904697A (en) * | 1987-04-09 | 1990-02-27 | Merrell Dow Pharmaceuticals Inc. | Controlling the growth of certain tumor tissue with chalcone derivatives |
| US4753965A (en) * | 1987-04-09 | 1988-06-28 | Merrell Dow Pharmaceuticals, Inc. | Method of treating multiple sclerosis with chalcone derivatives |
| EP0328668B1 (en) * | 1987-07-23 | 1994-05-25 | Nippon Oil And Fats Company, Limited | Nonlinear optical material |
| EP0328669A4 (en) * | 1987-07-25 | 1989-10-12 | Nippon Oils & Fats Co Ltd | CONNECTIONS DERIVED FROM CHALCONES. |
| IL114760A (en) * | 1991-02-08 | 1997-11-20 | Lilly Co Eli | Ring-substituted-2-amino-1,2,3,4-tetrahydronaphthalenes and 3-aminochromanes intermediates thereto |
| DE69330403T2 (de) | 1992-03-06 | 2002-06-06 | Lica Pharmaceutical A/S, Copenhagen/Kopenhagen | Behandlung und prophylaxe von durch parasiten oder bakterien verursachten erkrankungen |
| US5276058A (en) * | 1993-06-09 | 1994-01-04 | Nippon Hypox Laboratories Incorporated | 3,4-dihydroxychalcone derivatives |
| IL118657A0 (en) * | 1996-06-14 | 1996-10-16 | Arad Dorit | Inhibitors for picornavirus proteases |
| IL122591A0 (en) | 1997-12-14 | 1998-06-15 | Arad Dorit | Pharmaceutical compositions comprising cystein protease inhibitors |
| US7714025B2 (en) * | 2006-05-10 | 2010-05-11 | Arizona Biomedical Research Commission | Modified chalcone compounds as antimitotic agents |
| US7781410B2 (en) * | 2006-08-04 | 2010-08-24 | Johnson & Johnson Consumer Companies, Inc. | Compositions containing chalcones and use thereof |
| KR100830541B1 (ko) * | 2006-08-11 | 2008-05-21 | 충남대학교산학협력단 | 인터루킨-5 저해효과를 갖는 신규 찰콘계 유도체 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS598249B2 (ja) * | 1974-01-19 | 1984-02-23 | 大正製薬株式会社 | カルコン類の合成法 |
| JPS5912094B2 (ja) * | 1974-01-19 | 1984-03-21 | 大正製薬株式会社 | カルコン体の合成法 |
| JPS598250B2 (ja) * | 1974-02-09 | 1984-02-23 | 大正製薬株式会社 | カルコンエ−テルの合成法 |
| CH593224A5 (cg-RX-API-DMAC7.html) * | 1973-10-30 | 1977-11-30 | Taisho Pharmaceutical Co Ltd | |
| JPS598251B2 (ja) * | 1974-04-19 | 1984-02-23 | 大正製薬株式会社 | イソプレニルカルコン類の合成法 |
| JPS593460B2 (ja) * | 1974-04-19 | 1984-01-24 | 大正製薬株式会社 | カルコンルイ ノ ゴウセイホウ |
| JPS50140430A (cg-RX-API-DMAC7.html) * | 1974-04-23 | 1975-11-11 | ||
| US4279930A (en) * | 1978-10-10 | 1981-07-21 | The Upjohn Company | Process for treating inflammation |
-
1980
- 1980-01-17 NZ NZ192641A patent/NZ192641A/en unknown
- 1980-01-18 CA CA343,964A patent/CA1124254A/en not_active Expired
- 1980-01-18 ZA ZA00800312A patent/ZA80312B/xx unknown
- 1980-01-18 AU AU54744/80A patent/AU537855B2/en not_active Ceased
- 1980-01-18 MC MC801422A patent/MC1303A1/fr unknown
- 1980-01-21 DE DE8080100273T patent/DE3061010D1/de not_active Expired
- 1980-01-21 IL IL59180A patent/IL59180A/xx unknown
- 1980-01-21 EP EP80100273A patent/EP0013960B1/de not_active Expired
- 1980-01-21 AT AT80100273T patent/ATE1744T1/de not_active IP Right Cessation
- 1980-01-22 HU HU80123A patent/HU183108B/hu not_active IP Right Cessation
- 1980-01-24 PT PT70729A patent/PT70729A/pt unknown
- 1980-01-24 GR GR61032A patent/GR73099B/el unknown
- 1980-01-24 AR AR279737A patent/AR228131A1/es active
- 1980-01-24 FI FI800212A patent/FI70699C/fi not_active IP Right Cessation
- 1980-01-25 IE IE145/80A patent/IE49502B1/en unknown
- 1980-01-25 NO NO800176A patent/NO151702C/no unknown
- 1980-01-25 YU YU00199/80A patent/YU19980A/xx unknown
- 1980-01-25 PH PH23551A patent/PH16033A/en unknown
- 1980-01-25 ES ES488013A patent/ES8101532A1/es not_active Expired
- 1980-01-25 DK DK32780A patent/DK32780A/da not_active Application Discontinuation
- 1980-01-25 BR BR8000507A patent/BR8000507A/pt unknown
- 1980-01-25 JP JP700880A patent/JPS567736A/ja active Pending
- 1980-01-28 CS CS80577A patent/CS214819B2/cs unknown
- 1980-09-16 ES ES495076A patent/ES495076A0/es active Granted
-
1984
- 1984-04-24 US US06/602,633 patent/US4605674A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| PH16033A (en) | 1983-06-02 |
| PT70729A (en) | 1980-02-01 |
| GR73099B (cg-RX-API-DMAC7.html) | 1984-02-01 |
| IE49502B1 (en) | 1985-10-16 |
| NO151702B (no) | 1985-02-11 |
| NO151702C (no) | 1985-05-22 |
| NZ192641A (en) | 1984-10-19 |
| ATE1744T1 (de) | 1982-11-15 |
| ES8107142A1 (es) | 1981-10-01 |
| ES495076A0 (es) | 1981-10-01 |
| US4605674A (en) | 1986-08-12 |
| ES488013A0 (es) | 1980-12-16 |
| NO800176L (no) | 1980-07-28 |
| DK32780A (da) | 1980-07-27 |
| AU5474480A (en) | 1980-07-31 |
| HU183108B (en) | 1984-04-28 |
| IL59180A0 (en) | 1980-05-30 |
| FI70699B (fi) | 1986-06-26 |
| YU19980A (en) | 1983-12-31 |
| AR228131A1 (es) | 1983-01-31 |
| FI70699C (fi) | 1986-10-06 |
| EP0013960A1 (de) | 1980-08-06 |
| EP0013960B1 (de) | 1982-11-03 |
| BR8000507A (pt) | 1980-10-29 |
| FI800212A7 (fi) | 1980-07-27 |
| CS214819B2 (en) | 1982-06-25 |
| CA1124254A (en) | 1982-05-25 |
| MC1303A1 (fr) | 1980-10-03 |
| ZA80312B (en) | 1981-01-28 |
| AU537855B2 (en) | 1984-07-19 |
| DE3061010D1 (en) | 1982-12-09 |
| JPS567736A (en) | 1981-01-27 |
| IE800145L (en) | 1980-07-26 |
| IL59180A (en) | 1983-05-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES8101532A1 (es) | Un procedimiento para la preparacion de acetofenonas substi-tuidas | |
| ES8400737A1 (es) | "un procedimiento para preparar derivados de nicotinamida". | |
| ES8204739A1 (es) | Un procedimiento para preparar compuestos de cefem | |
| DK370682A (da) | Fremgangsmaade til fremstilling af carbapenemderivater | |
| ES2044836T3 (es) | Derivado de la piperidina, su utilizacion y compuesto farmaceutico que lo contiene. | |
| ES8200654A1 (es) | Un metodo de preparar compuestos de sulfonilo | |
| IL65801A (en) | 1-substituted spiro-(piperidineoxobenzoxazine)s,their preparation and pharmaceutical compositions containing them | |
| ES444870A1 (es) | Procedimiento para preparar derivados de oxadiazolinona. | |
| MY141488A (en) | Hydroximic acid derivatives, processes for their preparation, and compositions comprising them | |
| ES475635A1 (es) | Procedimiento para preparar derivados de imidazol. | |
| MY103502A (en) | Novel compounds | |
| MY108849A (en) | Novel compound | |
| ES472877A1 (es) | Procedimiento para preparar derivados de 25-alquilcolesterol | |
| ES8500269A1 (es) | Procedimiento para la fabricacion de un derivado de azolcarboxamida n,n-subsitutida. | |
| ES8304971A1 (es) | Un procedimiento para la preparacion de derivados de tiocarbapenem 3-sustituidos. | |
| DE3271901D1 (en) | Heterocyclic compounds useful as pesticides and processes for making them | |
| ES8305742A1 (es) | Un procedimiento para la preparacion de un derivado de tetrazol. | |
| ES8105748A1 (es) | Procedimiento para preparar derivados de pirimidina | |
| ES8100249A1 (es) | Un metodo para la preparacion de un compuesto de acido hi- droxamico | |
| ES8304920A1 (es) | Un procedimiento para preparar derivados de n-acil-n-hidroxi-a minoacidos. | |
| GB1361816A (en) | Longitudinal cell growth inhibiting composition | |
| MY121785A (en) | Hydroxamic acid derivatives as inhibitors of the production of soluble cd23 | |
| ES459705A1 (es) | Procedimiento para la preparacion de derivados de hidracina-piridacina. | |
| ES468532A1 (es) | Un procedimiento para preparar un compuesto de sulfonio re- gulador del crecimiento de las plantas | |
| JPS5359664A (en) | Novel imidazole derivatives |